Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 1,205 INR
Change Today +70.35 / 6.20%
Volume 1.7M
As of 7:05 AM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

aurobindo pharma ltd (ARBP) Snapshot

Open
1,143
Previous Close
1,135
Day High
1,217
Day Low
1,141
52 Week High
03/19/15 - 1,280
52 Week Low
03/31/14 - 503.40
Market Cap
351.9B
Average Volume 10 Days
1.7M
EPS TTM
40.27
Shares Outstanding
292.0M
EX-Date
02/16/15
P/E TM
29.9x
Dividend
2.00
Dividend Yield
0.44%
Current Stock Chart for AUROBINDO PHARMA LTD (ARBP)

Related News

No related news articles were found.

aurobindo pharma ltd (ARBP) Related Businessweek News

No Related Businessweek News Found

aurobindo pharma ltd (ARBP) Details

Aurobindo Pharma Limited, a pharmaceutical company, develops, manufactures, and markets generic pharmaceuticals and active pharmaceutical ingredients in India, the United States, Europe, and internationally. The company offers generics formulations primarily in the therapeutic areas of cardiovascular system, central nervous system, antibacterials, cephalosporins, opthalmics, oral contraceptives, gastroenterologicals, NSAIDS, anti-fungal, anti-emetics, anti-virals, anti-diabetics, anti-allergic, antibiotics, anti-retrovirals, and others. The company was founded in 1986 and is headquartered in Hyderabad, India.

9,500 Employees
Last Reported Date: 08/1/14
Founded in 1986

aurobindo pharma ltd (ARBP) Top Compensated Officers

Managing Director and Director
Total Annual Compensation: 15.9M
Whole Time Director, Member of Corporate Soci...
Total Annual Compensation: 9.0M
Vice Chairman, Chairman of Corporate Social R...
Total Annual Compensation: 9.0M
Whole Time Director and Member of Shareholder...
Total Annual Compensation: 9.0M
Compensation as of Fiscal Year 2014.

aurobindo pharma ltd (ARBP) Key Developments

Aurobindo Pharma Appoints Avnit Bimal Singh as an Additional Director (Non-Executive, Independent) on the Board

Aurobindo Pharma Ltd. announced that it has appointed Avnit Bimal Singh as an additional director (non-executive, independent) on the board of the company with effect from March 25, 2015.

Aurobindo Pharma Limited Receives FDA Approval for Lacosamide Tablets

The tentative approval for Lacosamide Tablets 50mg, 100mg, 150mg and 200mg (ANDA 204994) has been obtained by Aurobindo Pharma Limited from US Food & Drug Administration (USFDA). The generic equivalent of USB Inc. s Vimpat Tablets are Lacosamide Tablets and it is utilized in the treatment of partial-onset seizures in patients with epilepsy aged 17 years and older with a market size of approximately $593 million for the twelve months ending January 2015.

Aurobindo Pharma Limited Presents at Merrill Lynch - India Investor Conference Jaipur, Mar-11-2015

Aurobindo Pharma Limited Presents at Merrill Lynch - India Investor Conference Jaipur, Mar-11-2015 . Venue: Fairmont, Jaipur, Rajasthan, India.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARBP:IN 1,205.10 INR +70.35

ARBP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biocon Ltd 425.05 INR -6.40
Cipla Ltd/India 694.00 INR 0.00
Divi's Laboratories Ltd 1,794 INR 0.00
Ranbaxy Laboratories Ltd 805.20 INR 0.00
Shasun Pharmaceuticals Ltd 343.50 INR 0.00
View Industry Companies
 

Industry Analysis

ARBP

Industry Average

Valuation ARBP Industry Range
Price/Earnings 21.1x
Price/Sales 3.1x
Price/Book 7.7x
Price/Cash Flow 17.6x
TEV/Sales 2.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AUROBINDO PHARMA LTD, please visit www.aurobindo.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.